Last reviewed · How we verify

NCT07108205

Image Quality Study of Spectral Precise Image CT 7700

Completed Last updated 15 December 2025
What this trial tests

trial testing Paired reading analysis in Head in 126 participants. Completed in 14 October 2025.

Timeline
16 July 2025
Primary endpoint
14 October 2025
14 October 2025

Quick facts

Lead sponsorPhilips Clinical & Medical Affairs Global
StatusCompleted
Study typeOBSERVATIONAL
Enrollment126
Start date16 July 2025
Primary completion14 October 2025
Estimated completion14 October 2025
Sites3 locations across United States

Drugs / interventions tested

Conditions studied

Sponsor

Philips Clinical & Medical Affairs Global — full company profile →

Who can join

22 and older, any sex, with Head or Body. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of the study is to evaluate the Image Quality (IQ), and diagnostic confidence of Spectral Precise Image for CT 7700 Scanner as compared with iDose4 as a standard-of-care reference.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Philips Clinical & Medical Affairs Global trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07108205.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing